Month: January 2025

Recombinant adeno-associated viruses (rAAVs) are indispensable in neuroscience and gene therapy, offering tools to study and manipulate specific cellular populations. Among these, rAAV-GFAP(681)-hM3D(Gq)-mCherry-WPREs is designed for selective targeting and activation of astrocytes using chemogenetics. This article examines its structure, applications, advantages, challenges, and future possibilities, supported by authoritative resources for further learning. Structural Overview of…

Recombinant adeno-associated viruses (rAAVs) have become indispensable in the fields of gene therapy, molecular biology, and neuroscience. Among these, rAAV-CMV-EGFP-WPRE-bGH polyA is a prominent construct known for its robust expression and versatility. This article explores the structure, applications, advantages, challenges, and future directions of this construct, along with authoritative resources for further exploration. Structural Overview…

Recombinant adeno-associated viruses (rAAVs) are powerful tools in gene therapy and neuroscience, offering precise targeting and robust gene expression capabilities. Among these, rAAV-ChAT-hM3D(Gq)-WPREs stands out for its ability to target cholinergic neurons, enabling the study and modulation of these essential neural circuits. This article provides a detailed overview of the construct’s structure, applications, advantages, challenges,…